{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:53:56Z","timestamp":1790906036334,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-06024-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:06:52Z","timestamp":1783501612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guillain\u2013Barr\u00e9 syndrome following Plasmodium falciparum malaria in a child: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Simone","family":"Khalifeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Najm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"4","key":"6024_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/jns.12594","volume":"28","author":"PA van Doorn","year":"2023","unstructured":"van Doorn PA, Van den Bergh PYK, Hadden RDM, Avau B, Vankrunkelsven P, Attarian S, et al. European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst. 2023;28(4):535\u201363.","journal-title":"J Peripher Nerv Syst"},{"issue":"24","key":"6024_CR2","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012;366(24):2294\u2013304.","journal-title":"N Engl J Med"},{"issue":"11","key":"6024_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.71503","volume":"13","author":"HA Abdela","year":"2025","unstructured":"Abdela HA, Kimo NH, Woyimo TG. Guillain-Barr\u00e9 Syndrome Following Malaria: A Rare Case Report From Rural Ethiopia and Literature Review. Clin Case Rep. 2025;13(11):e71503.","journal-title":"Clin Case Rep"},{"issue":"1","key":"6024_CR4","first-page":"1047","volume":"3","author":"T Banks","year":"2020","unstructured":"Banks T, Bernardo FR, Majumdar A. Stridor as the Initial Presentation of Guillain-Barr\u00e9 Syndrome (GBS): Two Paediatric Cases. Annals of Pediatrics. 2020;3(1):1047.","journal-title":"Annals of Pediatrics"},{"issue":"1","key":"6024_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.33696\/mentalhealth.5.031","volume":"5","author":"CM Noioso","year":"2025","unstructured":"Noioso CM, Pecoraro A, Acerra GM, Avventura S, Bevilacqua L, Giordano C, et al. Expanding Horizons in Anti-GQ1b Antibody Syndrome: Recognizing Atypical and Overlap Forms. Journal of Mental Health Disorders. 2025;5(1):15\u201321.","journal-title":"Journal of Mental Health Disorders"},{"issue":"8093","key":"6024_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750\u20133.","journal-title":"Lancet"},{"issue":"1","key":"6024_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12883-025-04049-z","volume":"25","author":"MA Kebede","year":"2025","unstructured":"Kebede MA, Tekle AB, Eshetu MA, Shash EP, Berhanu MT, Ahmed ET, et al. Guillain-Barr\u00e9 syndrome following falciparum malaria infection: a case report. BMC Neurol. 2025;25(1):37.","journal-title":"BMC Neurol"},{"issue":"9","key":"6024_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.70932","volume":"13","author":"GA Getahun","year":"2025","unstructured":"Getahun GA, Arega G, Jemal MK, Woldie BG, Gudina EK. Guillain-Barr\u00e9 Syndrome Following Falciparum Malaria in an 18-Year Male Adolescent: A Rare Case Report and Literature Review. Clin Case Rep. 2025;13(9):e70932.","journal-title":"Clin Case Rep"},{"key":"6024_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2025.100824","volume":"55","author":"S Soomro","year":"2025","unstructured":"Soomro S, Alam M, Akber H, Ismail S, Abbasi LI, Herekar FF. Malaria a culprit of Gullian Barre Syndrome (GBS): A case report. Indian J Med Microbiol. 2025;55:100824.","journal-title":"Indian J Med Microbiol"},{"key":"6024_CR10","unstructured":"Guillain G, Barr\u00e9 J, Strohl A. Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquid cephalorachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendinaux. Bulletins et M\u00e9moires de la Soci\u00e9t\u00e9 M\u00e9dicale des H\u00f4pitaux de Paris. 1916;40:1462\u201370."},{"issue":"Pt 10","key":"6024_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/123.10.2171","volume":"123","author":"M Mori","year":"2000","unstructured":"Mori M, Kuwabara S, Miyake M, Noda M, Kuroki H, Kanno H, et al. Haemophilus influenzae infection and Guillain-Barr\u00e9 syndrome. Brain. 2000;123(Pt 10):2171\u20138.","journal-title":"Brain"},{"issue":"6","key":"6024_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","volume":"82","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, et al. Guillain-Barr\u00e9 syndrome associated with preceding hepatitis E virus infection. Neurology. 2014;82(6):491\u20137.","journal-title":"Neurology"},{"issue":"10027","key":"6024_CR13","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, Last\u00e8re S, Roche C, Vanhomwegen J, et al. Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531\u20139.","journal-title":"Lancet"},{"issue":"6","key":"6024_CR14","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/cid\/ciz625","volume":"70","author":"S Stegmann-Planchard","year":"2020","unstructured":"Stegmann-Planchard S, Gallian P, Tressi\u00e8res B, Leparc-Goffart I, Lannuzel A, Signat\u00e9 A, et al. Chikungunya, a Risk Factor for Guillain-Barr\u00e9 Syndrome. Clin Infect Dis. 2020;70(6):1233\u20135.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"6024_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ana.26339","volume":"91","author":"JA Frontera","year":"2022","unstructured":"Frontera JA, Tamborska AA, Doheim MF, Garcia-Azorin D, Gezegen H, Guekht A, et al. Neurological Events Reported after COVID-19 Vaccines: An Analysis of VAERS. Ann Neurol. 2022;91(6):756\u201371.","journal-title":"Ann Neurol"},{"key":"6024_CR16","doi-asserted-by":"publisher","unstructured":"Omari AAA, Gamble CL, Garner P. Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005965. https:\/\/doi.org\/10.1002\/14651858.CD005965.","DOI":"10.1002\/14651858.CD005965"},{"issue":"11","key":"6024_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1475-2875-11-176.PMID:22632033;PMCID:PMC3416680","volume":"25","author":"A F\u00e4rnert","year":"2012","unstructured":"F\u00e4rnert A, Ursing J, Tolfvenstam T, Rono J, Karlsson L, Sparrelid E, et al. Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania. Malar J. 2012;25(11):176. https:\/\/doi.org\/10.1186\/1475-2875-11-176.PMID:22632033;PMCID:PMC3416680.","journal-title":"Malar J"},{"key":"6024_CR18","doi-asserted-by":"publisher","unstructured":"Sond\u00e9n K, Wyss K, Jovel I, Vieira da Silva A, Pohanka A, Asghar M, Homann MV, Gustafsson LL, Hellgren U, F\u00e4rnert A. High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series. Clin Infect Dis. 2017 Jan 15;64(2):199\u2013206. https:\/\/doi.org\/10.1093\/cid\/ciw710. Epub 2016 Oct 24. PMID: 27986683.","DOI":"10.1093\/cid\/ciw710"},{"key":"6024_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00436-024-08301-2","volume":"123","author":"CS Milong Melong","year":"2024","unstructured":"Milong Melong CS, Peloewetse E, Russo G, et al. An overview of artemisinin-resistant malaria and associated Pfk13 gene mutations in Central Africa. Parasitol Res. 2024;123:277. https:\/\/doi.org\/10.1007\/s00436-024-08301-2.","journal-title":"Parasitol Res"},{"issue":"1","key":"6024_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13613-025-01464-w","volume":"15","author":"N Weiss","year":"2025","unstructured":"Weiss N, Marois C, Le Guennec L, Rohaut B, Demeret S. Critical insights for intensivists on Guillain-Barr\u00e9 syndrome. Ann Intensive Care. 2025;15(1):67.","journal-title":"Ann Intensive Care"},{"key":"6024_CR21","doi-asserted-by":"crossref","unstructured":"Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2017;2(2):Cd001798.","DOI":"10.1002\/14651858.CD001798.pub3"},{"issue":"10","key":"6024_CR22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1212\/WNL.38.10.1639","volume":"38","author":"RP Kleyweg","year":"1988","unstructured":"Kleyweg RP, van der Mech\u00e9 FG, Meulstee J. Treatment of Guillain-Barr\u00e9 syndrome with high-dose gammaglobulin. Neurology. 1988;38(10):1639\u201341.","journal-title":"Neurology"},{"issue":"Pt 9","key":"6024_CR23","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes RA, Swan AV, Rapha\u00ebl JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review. Brain. 2007;130(Pt 9):2245\u201357.","journal-title":"Brain"},{"key":"6024_CR24","doi-asserted-by":"crossref","unstructured":"Zaki HA, Iftikhar H, Najam M, Masood M, Al-Marri NDR, Elgassim MAM, et al. Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barr\u00e9 syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis. eNeurologicalSci. 2023;31:100468.","DOI":"10.1016\/j.ensci.2023.100468"},{"issue":"3","key":"6024_CR25","volume":"16","author":"S SavithriNandeesha","year":"2024","unstructured":"SavithriNandeesha S, Kasagga A, Hawrami C, Ricci E, Hailu KT, Salib K, et al. Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barr\u00e9 Syndrome Management: A Systematic Review. Cureus. 2024;16(3):e57066.","journal-title":"Cureus"},{"issue":"1","key":"6024_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1756285615610471","volume":"9","author":"K Saad","year":"2016","unstructured":"Saad K, Mohamad IL, Abd El-Hamed MA, Tawfeek MS, Ahmed AE, Abdel Baseer KA, et al. A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barr\u00e9 syndrome in Upper Egypt. Ther Adv Neurol Disord. 2016;9(1):3\u20138.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"6024_CR27","first-page":"296","volume":"14","author":"J Anwer","year":"2020","unstructured":"Anwer J, Khalid S, UlHaq R, Iqbal R, Mahmood Z, Tayyab H. Outcome of various treatments in Guillain-Barr\u00e9 Syndrome in Children. Pakistan Journal of Medical and Health Sciences. 2020;14(1):296\u20138.","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"issue":"4","key":"6024_CR28","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/cc10305","volume":"15","author":"MA El-Bayoumi","year":"2011","unstructured":"El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 syndrome: a randomized study. Crit Care. 2011;15(4):R164.","journal-title":"Crit Care"},{"key":"6024_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1472-6963-11-101","volume":"11","author":"JL Winters","year":"2011","unstructured":"Winters JL, Brown D, Hazard E, Chainani A, Andrzejewski C Jr. Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barr\u00e9 syndrome. BMC Health Serv Res. 2011;11:101.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"6024_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yapd.2023.04.001","volume":"70","author":"MM Langille","year":"2023","unstructured":"Langille MM. Guillain-Barre Syndrome in Children and Adolescents. Adv Pediatr. 2023;70(1):91\u2013103.","journal-title":"Adv Pediatr"},{"issue":"1","key":"6024_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/jns.12434","volume":"26","author":"I Hasan","year":"2021","unstructured":"Hasan I, Papri N, Hayat S, Jahan I, Ara G, Islam B, et al. Clinical and serological prognostic factors in childhood Guillain-Barr\u00e9 syndrome: A prospective cohort study in Bangladesh. J Peripher Nerv Syst. 2021;26(1):83\u20139.","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"6024_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/dmcn.15418","volume":"65","author":"H Qinrong","year":"2023","unstructured":"Qinrong H, Yuxia C, Ling L, Huayu L, Lei X, Xiaoli L, et al. Reliability and validity of prognostic indicators for Guillain-Barr\u00e9 syndrome in children. Dev Med Child Neurol. 2023;65(4):563\u201370.","journal-title":"Dev Med Child Neurol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-06024-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:02:26Z","timestamp":1790902946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-06024-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6024"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-06024-6","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SK, FH, RS, AN, CS, and AI declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was prepared in accordance with the Declaration of Helsinki. Written informed consent to participate was obtained from the patient\u2019s parents\/legal guardians. Ethical approval was not required for publication of a single de\u2011identified case report in accordance with local institutional policy (committee name\/reference number: not applicable\/available upon request).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of this case report and any accompanying images was obtained from the patient\u2019s parents\/legal guardians. A copy of the written consent is available for review by the Editor upon request.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"346"}}